Status:
TERMINATED
The PSVT Place Registry.Paroxysmal Supraventricular Tachycardia (PSVT) Registry.
Lead Sponsor:
Milestone Pharmaceuticals Inc.
Conditions:
Paroxysmal Supraventricular Tachycardia (PSVT)
Eligibility:
All Genders
Brief Summary
Paroxysmal supraventricular tachycardia (PSVT) is a sporadic, sudden, and recurring tachycardia that is caused by an altered electrical conductivity in the heart. It causes palpitations and a rapid he...
Eligibility Criteria
Inclusion
- A participant must meet all of the following criteria to be eligible for participation in the study:
- Adult male or female.
- Participant has suspected PSVT as per the online prescreening assessment.
- Participant lives in a country in which the registry is being conducted.
- Participant has signed the informed consent form indicating he/she is able to complete the online registry data collection forms on his/her own.
Exclusion
- Participant does not have an email address.
- Participant does not set up a user account.
Key Trial Info
Start Date :
October 16 2017
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
March 16 2020
Estimated Enrollment :
354 Patients enrolled
Trial Details
Trial ID
NCT03353610
Start Date
October 16 2017
End Date
March 16 2020
Last Update
December 3 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
MAPI
Lexington, Kentucky, United States, 40504